Dry Eye

Optimizing the ocular surface to achieve full visual potential continues after surgery

Ophthalmologists should instruct their patients to pay attention to their eye health for the long term.

Bausch + Lomb, Novaliq announce U.S. FDA filing acceptance for investigational treatment NOV03

A potential first-in-class eye drop with a novel mechanism of action, NOV03 is an investigational therapy to treat the signs and symptoms of dry eye disease associated with Meibomian gland dysfunction.

Aerie Pharmaceuticals publishes results of COMET-1 Phase 2b study

Although predefined co-primary study endpoints were not met, AR-15512 demonstrated statistically significant improvements in DED signs, symptoms, and disease-related quality of life.